269 related articles for article (PubMed ID: 21349410)
1. New and emerging syndromes due to neuroendocrine tumors.
Vinik AI; Gonzales MR
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):19-63, vii. PubMed ID: 21349410
[TBL] [Abstract][Full Text] [Related]
2. Clinical Presentation and Diagnosis of Neuroendocrine Tumors.
Vinik AI; Chaya C
Hematol Oncol Clin North Am; 2016 Feb; 30(1):21-48. PubMed ID: 26614367
[TBL] [Abstract][Full Text] [Related]
3. Gastroenteropancreatic neuroendocrine tumors. Where are we now?
Castellano D
Cancer Metastasis Rev; 2011 Mar; 30 Suppl 1():1. PubMed ID: 21365184
[No Abstract] [Full Text] [Related]
4. The clinical relevance of chromogranin A as a biomarker for gastroenteropancreatic neuroendocrine tumors.
Lawrence B; Gustafsson BI; Kidd M; Pavel M; Svejda B; Modlin IM
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):111-34, viii. PubMed ID: 21349414
[TBL] [Abstract][Full Text] [Related]
5. Circulating biomarkers in neuroendocrine tumors of the enteropancreatic tract: application to diagnosis, monitoring disease, and as prognostic indicators.
Ardill JE; O'Dorisio TM
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):777-90. PubMed ID: 21095544
[TBL] [Abstract][Full Text] [Related]
6. Measuring the relationship of quality of life and health status, including tumor burden, symptoms, and biochemical measures in patients with neuroendocrine tumors.
Vinik E; Silva MP; Vinik AI
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):97-109, viii. PubMed ID: 21349413
[TBL] [Abstract][Full Text] [Related]
7. Laboratory tests for neuroendocrine tumours.
Seregni E; Ferrari L; Stivanello M; Dogliotti L
Q J Nucl Med; 2000 Mar; 44(1):22-41. PubMed ID: 10932599
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis of neuroendocrine tumours in the gastrointestinal tract].
Rehfeld JF; Friis-Hansen L; Gøtze JP; Hilsted L; Nielsen FC
Ugeskr Laeger; 2010 Oct; 172(43):2957-60. PubMed ID: 21040675
[TBL] [Abstract][Full Text] [Related]
9. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
[TBL] [Abstract][Full Text] [Related]
10. [Neuroendocrine tumours of pancreas and gastrointestinal tract].
Tsimmerman IaS
Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic endocrine tumors: diagnostic pitfalls.
Ectors N
Hepatogastroenterology; 1999; 46(26):679-90. PubMed ID: 10370596
[No Abstract] [Full Text] [Related]
12. Neuroendocrine gastroenteropancreatic tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up.
Oberg K; Jelic S;
Ann Oncol; 2008 May; 19 Suppl 2():ii104-5. PubMed ID: 18456741
[No Abstract] [Full Text] [Related]
13. [Diagnosis and surgical management in gastrointestinal neuroendocrine tumors].
Tomulescu V; Stănciulea O; Dima S; Herlea V; Stoica Mustafa E; Dumitraşcu T; Pechianu C; Popescu I
Chirurgia (Bucur); 2011; 106(2):151-61. PubMed ID: 21698857
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-2 promotes disease progression of neuroendocrine tumors.
Detjen KM; Rieke S; Deters A; Schulz P; Rexin A; Vollmer S; Hauff P; Wiedenmann B; Pavel M; Scholz A
Clin Cancer Res; 2010 Jan; 16(2):420-9. PubMed ID: 20068079
[TBL] [Abstract][Full Text] [Related]
15. [Neuroendocrine tumors of the gastroenteropancreatic system. Diagnosis and surgical treatment].
Schürmann G; Brüwer M; Senninger N
Dtsch Med Wochenschr; 2000 Apr; 125(15):461-4. PubMed ID: 10800444
[No Abstract] [Full Text] [Related]
16. Recent Updates on Neuroendocrine Tumors From the Gastrointestinal and Pancreatobiliary Tracts.
Kim JY; Hong SM
Arch Pathol Lab Med; 2016 May; 140(5):437-48. PubMed ID: 27128301
[TBL] [Abstract][Full Text] [Related]
17. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours].
Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U
Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672
[TBL] [Abstract][Full Text] [Related]
18. Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.
Janson ET; Sorbye H; Welin S; Federspiel B; Grønbæk H; Hellman P; Ladekarl M; Langer SW; Mortensen J; Schalin-Jäntti C; Sundin A; Sundlöv A; Thiis-Evensen E; Knigge U
Acta Oncol; 2014 Oct; 53(10):1284-97. PubMed ID: 25140861
[TBL] [Abstract][Full Text] [Related]
19. Prognostic and predictive biomarkers in gastroenteropancreatic neuroendocrine tumors.
Stevenson R; Libutti SK; Saif MW
JOP; 2013 Mar; 14(2):155-7. PubMed ID: 23474561
[TBL] [Abstract][Full Text] [Related]
20. Foreword: Gastroenteropancreatic system and its tumors: Part 2.
LeRoith D
Endocrinol Metab Clin North Am; 2011 Mar; 40(1):xiii-xv. PubMed ID: 21349407
[No Abstract] [Full Text] [Related]
[Next] [New Search]
